scholarly journals Successful endovascular treatment of severe chronic mesenteric ischemia (CMI) facilitated by Intra-operative positioning system (IOPS) image guidance

2021 ◽  
Author(s):  
Satish C. Muluk ◽  
Mahmoud Elrakhawy ◽  
Bart Chess ◽  
Carlos Rosales ◽  
Vikash Goel
Keyword(s):  
Endovascular Treatment ◽  
Mesenteric Ischemia ◽  
Image Guidance ◽  
Chronic Mesenteric Ischemia ◽  
Positioning System

scholarly journals Mid-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia

2011 ◽  
Vol 1 (1) ◽  
pp. 2 ◽  
Author(s):  
Eva Schönefeld ◽  
Susanne Szesny ◽  
Konstantinos P. Donas ◽  
Georgios A. Pitoulias ◽  
Giovanni Torsello
Keyword(s):  
Endovascular Treatment ◽  
Mesenteric Ischemia ◽  
Primary Patency ◽  
Mesenteric Arteries ◽  
Primary Study ◽  
Symptom Improvement ◽  
Initial Symptom ◽  
Secondary Patency ◽  
Chronic Mesenteric Ischemia

The authors would present the mid-term outcomes with the use of stent-supported angioplasty in the treatment of symptomatic chronic mesenteric ischemia (CMI). The present study is a retrospective analysis of 36 patients undergoing endovascular treatment of symptomatic CMI, between November 2000 and September 2009. Primary study endpoints were defined as primary patency, periprocedural and midterm mortality and complications, and symptom improvement after intervention. Forty-one mesenteric arteries (77.3% stenotic and 22.7% occluded vessels) were treated in 36 patients with 42 stents. In 30 patients (83.3%) one visceral artery and in 6 cases (16.7%) two visceral arteries were treated. Overall mortality was 16.7% (n=6) after a 60-month follow-up (mean follow-up period 30.1 months). Two early (<30-day) deaths were caused by visceral ischemia (n=2: 5.5%). Late death was procedure-related in one patient with re-occlusion of the superior mesenteric artery after 12 months. The other 3 patients died from non procedure-related causes; e.g. twice myocardial infarction. Initial symptom relief was observed in 29 patients (80.5%); 7 patients reported no change. Primary patency was 83.3% after 5 years and secondary patency was 90.5% (38 out of 42 stents) among all patients. Two conversions to open surgery were documented. First-line endovascular approach of CMI is a reasonable strategy. Close follow-up is mandatory due to symptom recurrence and restenosis.

scholarly journals Endovascular Treatment of Chronic Mesenteric Ischemia

2008 ◽  
Vol 72 (7) ◽  
pp. 1198-1200 ◽  
Author(s):  
Yoshimitsu Soga ◽  
Hiroyoshi Yokoi ◽  
Masashi Iwabuchi ◽  
Masakiyo Nobuyoshi
Keyword(s):  
Endovascular Treatment ◽  
Mesenteric Ischemia ◽  
Chronic Mesenteric Ischemia

scholarly journals Endovascular treatment of chronic mesenteric ischemia

2014 ◽  
Vol 6 (3) ◽  
pp. 118-124 ◽  
Author(s):  
Andreas Sundermeyer ◽  
Alexander Zapenko ◽  
Theodoros Moysidis ◽  
Bernd Luther ◽  
Knut Kröger
Keyword(s):  
Endovascular Treatment ◽  
Mesenteric Ischemia ◽  
Chronic Mesenteric Ischemia

scholarly journals Intravascular Ultrasound–Assisted Endovascular Treatment of Mesenteric Malperfusion in a Multichannel Aortic Dissection With Full True Lumen Collapse

2018 ◽  
Vol 26 (1) ◽  
pp. 83-87 ◽  
Author(s):  
Baolei Guo ◽  
Daqiao Guo ◽  
Zhenyu Shi ◽  
Zhihui Dong ◽  
Weiguo Fu
Keyword(s):  
Aortic Dissection ◽  
Endovascular Treatment ◽  
Intravascular Ultrasound ◽  
Mesenteric Ischemia ◽  
False Lumen ◽  
Patient Specific ◽  
Chronic Mesenteric Ischemia ◽  
True Lumen ◽  
True Lumen Collapse ◽  
Ivus Imaging

Purpose: To describe endovascular treatment of mesenteric malperfusion in a multichannel aortic dissection (MCAD) with full true lumen (TL) collapse following thoracic endovascular aortic repair (TEVAR). Case Report: A 54-year-old man presented with chronic mesenteric ischemia and a previous TEVAR for MCAD complicated by superior mesenteric artery (SMA) malperfusion. Computed tomography angiography (CTA) demonstrated a 3-channel aortic dissection with a “false-true-false” configuration. The SMA was malperfused through the collapsed TL. CTA also showed a secondary entry tear, measuring 18 mm in diameter, at the end of the previous endograft. Direct open surgery or endovascular revascularization of the SMA was not feasible. A plan was devised to improve SMA perfusion by increasing the TL inflow. With the assistance of intravascular ultrasound (IVUS), an endograft was placed through one false lumen in the abdominal aorta and through the TL in the descending thoracic aorta to seal the secondary entry tear. Symptoms of mesenteric ischemia resolved 2 days after the procedure. At 1 year, he is asymptomatic, has gained weight, and has improved SMA perfusion and remodeling of the 3-channel dissection on CTA. Conclusion: IVUS imaging can help evaluate the complex hemodynamics of MCAD. Patient-specific endovascular treatment of MCAD with mesenteric malperfusion seems to be a feasible bailout alternative treatment for urgent, complex cases without reconstruction options.

scholarly journals Role for Endovascular Therapy in Chronic Mesenteric Ischemia

2009 ◽  
Vol 23 (5) ◽  
pp. 365-373 ◽  
Author(s):  
Romaric Loffroy ◽  
Eric Steinmetz ◽  
Boris Guiu ◽  
Valérie Molin ◽  
Benjamin Kretz ◽  
...  
Keyword(s):  
Endovascular Treatment ◽  
Mesenteric Ischemia ◽  
Rare Condition ◽  
Primary Treatment ◽  
Transluminal Angioplasty ◽  
Mesenteric Arteries ◽  
Long Term Results ◽  
Chronic Mesenteric Ischemia ◽  
Interventional Devices

Chronic mesenteric ischemia is a rare condition that is caused by stenosis or occlusion of the mesenteric arteries and usually manifests as abdominal pain. While surgical revascularization has been the standard treatment for symptomatic patients, recent advances in interventional devices and techniques have made endovascular treatment feasible and effective. Percutaneous transluminal angioplasty with stent placement is now recognized as a minimally invasive means of obtaining good long-term results with an acceptable recurrence rate; consequently, the technique is suggested for the primary treatment of chronic mesenteric ischemia. The present article discusses the indications and principles of endovascular treatment, and reviews the literature, with emphasis on short- and long-term outcomes, particularly morbidity and mortality rates.

Sign in / Sign up

Export Citation Format

Share Document